<DOC>
	<DOCNO>NCT01315262</DOCNO>
	<brief_summary>Viagra ( Sildenafil citrate ) orally active selective inhibitor cyclic guanosine monophosphate ( cGMP ) -specific phosphodiesterase type 5 ( PDE5 ) use treatment erectile dysfunction ( ED ) . Objectives : - To test efficacy Viagra 100mg demand vs. Viagra 100mg daily ( take either bedtime 1 hour prior sexual intercourse ) restore erectile function follow radical prostatectomy . - To test safety tolerability Viagra 100 mg demand vs. Viagra 100 mg daily radical prostatectomy .</brief_summary>
	<brief_title>On Demand Versus Daily Sildenafil Patients Undergoing Radical Prostatectomy</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>1 . Subjects give write informed consent participate study . 2 . Men age 1865 year old . 3 . Weight range 50100 Kg . 4 . Subjects must stable relationship partner least 6 month willing attempt sexual intercourse . 5 . Normal preoperative erectile function ( define IIEFEF â‰¥ 26 ) without use therapy device improvement erection . 6 . Prostatic Specific Antigen ( PSA ) low 10 ng/ml . 7 . Clinical prostate cancer stage T1c T2 . 8 . Biopsy Gleason sum &lt; 8 . 9 . Able read , understand provide sign informed consent . Intraoperative inclusion criterion : 10 . Bilateral nerve spar radical prostatectomy ( open robotic assist radical prostatectomy accept ) define surgeon . Postoperative inclusion criterion : 11 . Histologicallyconfirmed , organconfined prostate cancer disease ( define , Gleason 6 7 , pathological stage T2 T3a R0 N0 ) . Subjects present follow included trial : 1 . Subjects sexual activity inadvisable opinion investigator significant cardiovascular disease last 6 month ; include cardiac failure , myocardial infarction , unstable angina , stroke transient ischemic attack ( TIA ) , symptomatic clinically significant cardiac arrhythmia include atrial fibrillation . 2 . Subjects medical history major hematological , renal , vascular hepatic abnormality , psychological social circumstance would impair ability participate reliably study , may increase risk others participate study . 3 . Subjects medical history diabetes . 4 . Subjects develop postoperative complication , namely reoperation hemorrhage , document urinary fistula indwell catheter 3 week . 5 . Subjects treat neoadjuvant radiotherapy hormonotherapy . 6 . Subjects receive receive PDE5 inhibitor . 7 . Subjects know hypersensitivity Viagra component study medication . 8 . Subjects rest sit hypotension ( BP &lt; 90/50 mmHg ) , hypertension ( BP &gt; 170/110 mmHg ) orthostatic hypotension . 9 . Subjects severe hepatic ; cirrhosis ALT ( Alanine aminotransferase ) 2x upper limit normal ) renal impairment ( creatinine clearance 30mL/min ) know history hereditary degenerative retinal disorder retinitis pigmentosa . 10 . Subjects , medical reason and/or opinion investigator , require start dose 25mg Viagra . 11 . Subjects currently take likely treat nitrate nitric oxide donor form ( oral , sublingual , buccal , transdermal , inhalational aerosol ) either regular intermittent basis . 12 . Subjects receive concomitant treatment study likely start treatment potent CYP3A4 CYP2C9 inhibitor ( e.g . protease inhibitor ritonavir saquinavir , ketoconazole , itraconazole , Miconazole , nefazadone , claritromycin , troleandomycin erythromycin cimetidine ) . 13 . Subjects currently use commercially available treatment noncommercial herbal preparation erectile dysfunction , e.g . IC injection , vacuum device , testosterone patch . Such treatments/devices must use time study . 14 . Subjects receive investigational drug within six week prior screen take investigational drug concomitantly . 15. previous prostate surgery previous hormonal treatment . 16 . Subjects increase risk priapism e.g . sickle cell disease , multiple myeloma , anatomical deformation penis ( angulation , cavernosal fibrosis Peyronie 's disease ) myeloproliferative disorder ( e.g . myeloid leukemia , polycythemia , thrombocytopenia ) . 17 . Subjects form sexual dysfunction ( e.g . retrograde ejaculation , unejaculation , painful ejaculation , premature ejaculation , hypoactive sexual desire inhibit absent orgasm ) . 18 . Subjects , opinion investigator , abuse alcohol drug . 19 . Subjects , opinion investigator , likely complete event log follow study instruction . 20 . Subjects , opinion investigator , likely complete study whatever reason .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Sildenafil 100</keyword>
	<keyword>restore erectile function radical prostatectomy</keyword>
</DOC>